Free MSHR seminar 


Kate Mounsey presents ‘Investigating the molecular basis of emerging ivermectin resistance in scabies mites’, on Monday 6 November from 12pm to 1pm.

Scabies has remained a worldwide problem for centuries, although its importance is frequently underestimated. While ivermectin is widely used in the treatment of scabies, the first cases of clinical and in vitro resistance of scabies mites to ivermectin were recently documented, raising concerns regarding its long-term sustainability.

Kate Mounsey’s study involved the identification and characterisation of several candidate ivermectin resistance genes from Sarcoptes scabiei, including ABC-transporters, Glutathione-S-transferases and a novel ligand-gated chloride channel. The work has provided new insights into the biology of scabies mites and the basis of emerging ivermectin resistance.

Kate is a PhD candidate with the Scabies and Skin Pathogen Research Lab at the Menzies School of Health Research.

This seminar takes place in the Menzies Seminar Room, John Mathews Building, Royal Darwin Hospital Campus.

Visit the Menzies School of Health Research website.